Cargando…

Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancer

Claudin-2 is a trans-membrane protein—component of tight junctions in epithelial cells. Elevated claudin-2 expression has been reported in colorectal cancer (CRC). The aim of this study was to investigate the expression patterns of claudin-2 in human CRC samples and analyze its association with clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mezheyeuski, Artur, Strell, Carina, Hrynchyk, Ina, Guren, Tormod Kyrre, Dragomir, Anca, Doroshenko, Tatyana, Pashkova, Oksana, Gorgun, Julia, Ruksha, Kseniya, Pfeiffer, Per, Kure, Elin H., Sorbye, Halfdan, Edler, David, Martling, Anna, Glimelius, Bengt, Östman, Arne, Portyanko, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887004/ https://www.ncbi.nlm.nih.gov/pubmed/29134439 http://dx.doi.org/10.1007/s00428-017-2263-3

Ejemplares similares

Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer
por: Mezheyeuski, Artur, et al.
Publicado: (2016)

Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II-III colon cancer
por: Mezheyeuski, Artur, et al.
Publicado: (2016)

Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer
por: Mezheyeuski, Artur, et al.
Publicado: (2019)

Over-Expression of βII-Tubulin and Especially Its Localization in Cell Nuclei Correlates with Poorer Outcomes in Colorectal Cancer
por: Ruksha, Kseniya, et al.
Publicado: (2019)

Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer
por: Thomsen, Maria, et al.
Publicado: (2016)

Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome
por: Thomsen, Maria, et al.
Publicado: (2018)

Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study
por: Guren, Tormod Kyrre, et al.
Publicado: (2017)

Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study
por: Tarpgaard, Line S., et al.
Publicado: (2014)

Let-7 miRNA-binding site polymorphism in the KRAS 3(′)UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/− cetuximab
por: Kjersem, Janne B, et al.
Publicado: (2012)

CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
por: Aasebø, Kristine, et al.
Publicado: (2020)

Consequences of a high incidence of microsatellite instability and BRAF‐mutated tumors: A population‐based cohort of metastatic colorectal cancer patients
por: Aasebø, Kristine Ø., et al.
Publicado: (2019)

Prognostic Interactions between FAP+ Fibroblasts and CD8a+ T Cells in Colon Cancer
por: Herrera, Mercedes, et al.
Publicado: (2020)

Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades: A Norwegian Population-Based Study
por: Hamfjord, Julian, et al.
Publicado: (2022)

TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: A potential novel approach to the treatment of metastatic colorectal cancer
por: Tarpgaard, Line S., et al.
Publicado: (2016)

High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer
por: Siesing, Christina, et al.
Publicado: (2017)

High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort
por: Sorbye, Halfdan, et al.
Publicado: (2015)

Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9
por: Winther, Stine Braendegaard, et al.
Publicado: (2017)

Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome
por: Mezheyeuski, Artur, et al.
Publicado: (2020)

Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort
por: Osterman, Erik, et al.
Publicado: (2020)

Multi‐parametric profiling of renal cell, colorectal, and ovarian cancer identifies tumour‐type‐specific stroma phenotypes and a novel vascular biomarker
por: Corvigno, Sara, et al.
Publicado: (2017)

Hospital factors and metastatic surgery in colorectal cancer patients, a population-based cohort study
por: Ljunggren, Malin, et al.
Publicado: (2022)

Sex differences in metastatic surgery following diagnosis of synchronous metastatic colorectal cancer
por: Ljunggren, Malin, et al.
Publicado: (2022)

The Immune Landscape of Colorectal Cancer
por: Mezheyeuski, Artur, et al.
Publicado: (2021)

Vessel size as a marker of survival in estrogen receptor positive breast cancer
por: Milosevic, Vladan, et al.
Publicado: (2023)

A Comprehensive Evaluation of Associations Between Routinely Collected Staging Information and The Response to (Chemo)Radiotherapy in Rectal Cancer
por: Hammarström, Klara, et al.
Publicado: (2020)

Fibroblasts—a key host cell type in tumor initiation, progression, and metastasis
por: Strell, Carina, et al.
Publicado: (2012)

An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers
por: Mezheyeuski, Artur, et al.
Publicado: (2023)

Low‐dose aspirin use and colorectal cancer survival in 32,195 patients—A national cohort study
por: Shahrivar, Mehrnoosh, et al.
Publicado: (2022)

Radiotherapy regimens for rectal cancer: long-term outcomes and health-related quality of life in the Stockholm III trial
por: Erlandsson, Johan, et al.
Publicado: (2022)

Health-Related Quality of Life in Colorectal Cancer Patients Treated With Liver Transplantation Compared to Chemotherapy
por: Smedman, Tor Magnus, et al.
Publicado: (2022)

Early radiologic signal of responsiveness to immune checkpoint blockade in microsatellite-stable/mismatch repair-proficient metastatic colorectal cancer
por: Meltzer, Sebastian, et al.
Publicado: (2022)

Topographical Distribution and Spatial Interactions of Innate and Semi-Innate Immune Cells in Pancreatic and Other Periampullary Adenocarcinoma
por: Lundgren, Sebastian, et al.
Publicado: (2020)

The claudins
por: Lal-Nag, Madhu, et al.
Publicado: (2009)

The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study
por: Liposits, Gabor, et al.
Publicado: (2022)

Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study
por: Liposits, Gabor, et al.
Publicado: (2021)

The level of claudin-7 is reduced as an early event in colorectal carcinogenesis
por: Bornholdt, Jette, et al.
Publicado: (2011)

Survival According to Primary Tumor Location, Stage, and Treatment Patterns in Locoregional Gastroenteropancreatic High-grade Neuroendocrine Carcinomas
por: Dasari, Arvind, et al.
Publicado: (2022)

Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer
por: Pettersson, D., et al.
Publicado: (2015)

On the Interaction of Clostridium perfringens Enterotoxin with Claudins
por: Veshnyakova, Anna, et al.
Publicado: (2010)

Occludin is required for apoptosis when claudin–claudin interactions are disrupted
por: Beeman, N, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_epv52o8oedpuh9orpb2qjkd1fa